These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 18666377)

  • 21. Epidemiology, clinical consequences, and psychosocial treatment of nonadherence in schizophrenia.
    Leucht S; Heres S
    J Clin Psychiatry; 2006; 67 Suppl 5():3-8. PubMed ID: 16822090
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A pilot study of barriers to medication adherence in schizophrenia.
    Hudson TJ; Owen RR; Thrush CR; Han X; Pyne JM; Thapa P; Sullivan G
    J Clin Psychiatry; 2004 Feb; 65(2):211-6. PubMed ID: 15003075
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Therapeutic benefit of a registered psychoeducation program on treatment adherence, objective and subjective quality of life: French pilot study for schizophrenia].
    Sauvanaud F; Kebir O; Vlasie M; Doste V; Amado I; Krebs MO
    Encephale; 2017 May; 43(3):235-240. PubMed ID: 27658989
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Improving treatment adherence in patients with schizophrenia.
    Kane JM
    J Clin Psychiatry; 2011 Sep; 72(9):e28. PubMed ID: 21951990
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Awareness of illness and nonadherence to antipsychotic medications among persons with schizophrenia.
    Olfson M; Marcus SC; Wilk J; West JC
    Psychiatr Serv; 2006 Feb; 57(2):205-11. PubMed ID: 16452697
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lack of insight in schizophrenia: impact on treatment adherence.
    Buckley PF; Wirshing DA; Bhushan P; Pierre JM; Resnick SA; Wirshing WC
    CNS Drugs; 2007; 21(2):129-41. PubMed ID: 17284095
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Medication adherence and hospitalization among patients with schizophrenia treated with antipsychotics.
    Lang K; Meyers JL; Korn JR; Lee S; Sikirica M; Crivera C; Dirani R; Menzin J
    Psychiatr Serv; 2010 Dec; 61(12):1239-47. PubMed ID: 21123409
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Therapeutic alliance, a stake in schizophrenia].
    Charpentier A; Goudemand M; Thomas P
    Encephale; 2009 Feb; 35(1):80-9. PubMed ID: 19250998
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Strategies for improving adherence to second-generation antipsychotics in patients with schizophrenia by increasing ease of use.
    Burton SC
    J Psychiatr Pract; 2005 Nov; 11(6):369-78. PubMed ID: 16304505
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relapse and therapeutic interventions in a 1-year observational cohort study of nonadherent outpatients with schizophrenia.
    Ciudad A; San L; Bernardo M; Olivares JM; Polavieja P; Valladares A; Gilaberte I
    Prog Neuropsychopharmacol Biol Psychiatry; 2012 Mar; 36(2):245-50. PubMed ID: 22056291
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Predictors of noncompliance in patients with schizophrenia.
    Perkins DO
    J Clin Psychiatry; 2002 Dec; 63(12):1121-8. PubMed ID: 12523871
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Adherence to antipsychotic medication in schizophrenia patients].
    Baloush-Kleinman V; Poyurovsky M; Koren D; Schneidman M; Weizman A; Shnitt D
    Harefuah; 2002 Dec; 141(12):1042-9, 1090. PubMed ID: 12534202
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Medication nonadherence and treatment outcome in patients with schizophrenia or schizoaffective disorder with suboptimal prior response.
    Lindenmayer JP; Liu-Seifert H; Kulkarni PM; Kinon BJ; Stauffer V; Edwards SE; Chen L; Adams DH; Ascher-Svanum H; Buckley PF; Citrome L; Volavka J
    J Clin Psychiatry; 2009 Jul; 70(7):990-6. PubMed ID: 19497244
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tactics and technologies to manage nonadherence in patients with schizophrenia.
    Glazer WM; Byerly MJ
    Curr Psychiatry Rep; 2008 Aug; 10(4):359-69. PubMed ID: 18627676
    [TBL] [Abstract][Full Text] [Related]  

  • 35. How do socio-demographic and clinical factors interact with adherence attitude profiles in schizophrenia? A cluster-analytical approach.
    Beck EM; Cavelti M; Wirtz M; Kossowsky J; Vauth R
    Psychiatry Res; 2011 May; 187(1-2):55-61. PubMed ID: 21074860
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interventions to improve adherence to antipsychotic medication in patients with schizophrenia--a review of the past decade.
    Barkhof E; Meijer CJ; de Sonneville LM; Linszen DH; de Haan L
    Eur Psychiatry; 2012 Jan; 27(1):9-18. PubMed ID: 21561742
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Good medical practice in antipsychotic pharmacotherapy.
    Peuskens J
    Int Clin Psychopharmacol; 1998 Mar; 13 Suppl 3():S35-41. PubMed ID: 9690969
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The relationship between patient satisfaction and treatment outcomes in schizophrenia.
    Chue P
    J Psychopharmacol; 2006 Nov; 20(6 Suppl):38-56. PubMed ID: 17046986
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Compliance and the rehabilitation alliance.
    Aquila R; Weiden PJ; Emanuel M
    J Clin Psychiatry; 1999; 60 Suppl 19():23-7; discussion 28-9. PubMed ID: 10507277
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Partial compliance in schizophrenia and the impact on patient outcomes.
    Llorca PM
    Psychiatry Res; 2008 Nov; 161(2):235-47. PubMed ID: 18849080
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.